Here's Why MakeMyTrip (MMYT) Fell More Than Broader Market

MakeMyTrip (MMYT) shares underperformed the market, closing down 2.94% while the S&P 500 fell 0.22%. The stock has depreciated 6.25% over the past month, lagging both the Computer and Technology sector and the S&P 500. Analysts anticipate the company's upcoming earnings report will show a 17.95% year-over-year EPS growth to $0.46 and an 8.88% increase in revenue to $277.12 million; however, the stock currently holds a Zacks Rank of #4 (Sell) and trades at a premium Forward P/E ratio of 47.81 compared to its industry's average of 16.99.

Analysis

MakeMyTrip (MMYT) is exhibiting a significant disconnect between its recent market performance and its forward-looking fundamental outlook. The stock has demonstrated notable weakness, closing down 2.94% in the latest session and depreciating 6.25% over the past month, substantially underperforming both the S&P 500 and the broader Computer and Technology sector. This negative momentum is underscored by a Zacks Rank of #4 (Sell). However, analyst consensus estimates project robust growth, with expectations for a 17.95% year-over-year increase in quarterly EPS to $0.46 and full-year earnings growth of 26.92%. This anticipated growth is paired with a steep valuation; MMYT trades at a Forward P/E ratio of 47.81, a significant premium to its industry's average of 16.99. The lack of upward revisions to the Zacks Consensus EPS estimate over the past 30 days suggests that while the long-term growth story is intact, there are no near-term catalysts compelling analysts to become more bullish, leaving the stock vulnerable given its high valuation and poor recent performance.

Key Decisions for Investors

• Investors should exercise caution due to the stock's high forward P/E of 47.81, which indicates that strong growth expectations are already priced in, increasing the risk of a significant correction if earnings disappoint.
• The upcoming earnings report is a critical catalyst; traders should monitor whether the company meets the high-bar consensus estimates for 17.95% EPS growth to justify its premium valuation.
• Given the conflict between strong growth forecasts and negative technical signals, including a 6.25% monthly decline and a #4 (Sell) rating, it may be prudent to await a more favorable entry point or a positive shift in analyst estimate revisions before initiating or adding to a position.